Diabetes and cancer: a consensus report
E Giovannucci, DM Harlan, MC Archer… - CA: a cancer journal …, 2010 - Wiley Online Library
Epidemiologic evidence suggests that cancer incidence is associated with diabetes as well
as certain diabetes risk factors and treatments. This consensus statement of experts …
as certain diabetes risk factors and treatments. This consensus statement of experts …
The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances
Metformin is a widely used drug in today's prescriptions by physicians due to its specific
effects in treating and curing type II diabetes. Diabetes is a common disease that may occur …
effects in treating and curing type II diabetes. Diabetes is a common disease that may occur …
Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis
Metformin, an insulin-lowering agent, has been associated with decreased cancer risk in
epidemiologic studies in diabetic patients. We performed a comprehensive literature search …
epidemiologic studies in diabetic patients. We performed a comprehensive literature search …
The relationship between diabetes mellitus and cancers and its underlying mechanisms
B Zhu, S Qu - Frontiers in Endocrinology, 2022 - frontiersin.org
Epidemiological studies suggest associations between diabetes mellitus and some cancers.
The risk of a number of cancers appears to be increased in diabetes mellitus. On the other …
The risk of a number of cancers appears to be increased in diabetes mellitus. On the other …
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
H Noto, A Goto, T Tsujimoto, M Noda - PloS one, 2012 - journals.plos.org
Background A growing body of evidence has suggested that metformin potentially reduces
the risk of cancer. Our objective was to enhance the precision of estimates of the effect of …
the risk of cancer. Our objective was to enhance the precision of estimates of the effect of …
Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders
Previous meta-analyses have shown that the antidiabetic agent metformin is associated with
reduced cancer incidence and mortality. However, this effect has not been consistently …
reduced cancer incidence and mortality. However, this effect has not been consistently …
Metformin and the risk of cancer: time-related biases in observational studies
OBJECTIVE Time-related biases in observational studies of drug effects have been
described extensively in different therapeutic areas but less so in diabetes. Immortal time …
described extensively in different therapeutic areas but less so in diabetes. Immortal time …
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
M Franciosi, G Lucisano, E Lapice, GFM Strippoli… - PloS one, 2013 - journals.plos.org
Aims/Hypothesis Diabetes treatments were related with either an increased or reduced risk
of cancer. There is ongoing debate about a potential protective action of metformin. To …
of cancer. There is ongoing debate about a potential protective action of metformin. To …
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
Background We previously reported that the incidence of hepatocellular carcinoma (HCC)
with non-viral etiologies increased rapidly between 1991 and 2010 in Japan. Methods To …
with non-viral etiologies increased rapidly between 1991 and 2010 in Japan. Methods To …
Understanding the benefit of metformin use in cancer treatment
RJO Dowling, PJ Goodwin, V Stambolic - BMC medicine, 2011 - Springer
Biguanides have been developed for the treatment of hyperglycemia and type 2 diabetes.
Recently, metformin, the most widely prescribed biguanide, has emerged as a potential …
Recently, metformin, the most widely prescribed biguanide, has emerged as a potential …